Profilo
Sandford Sommer is currently the President & Chief Operating Officer at Ligand UK Ltd.
He previously worked as the Director at UK Colombia Trade and as the President-Colombia operations at AstraZeneca PLC.
Posizioni attive di Sandford Sommer
| Società | Posizione | Inizio |
|---|---|---|
| VERNALIS | Presidente | 01/05/2016 |
Precedenti posizioni note di Sandford Sommer
| Società | Posizione | Fine |
|---|---|---|
| UK Colombia Trade | Direttore/Membro del Consiglio | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| UK Colombia Trade |
- Borsa valori
- Insiders
- Sandford Sommer
